HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Centralized Institutional Review Board (Cirb) for Minimal Risk Registry Linkage Studies. The project location is USA and the tender is closing on 08 Apr 2024. The tender notice number is 75N91024Q00068, while the TOT Ref Number is 99279237. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Centralized Institutional Review Board (Cirb) for Minimal Risk Registry Linkage Studies

Deadline : 08 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99279237

Document Ref. No. : 75N91024Q00068

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :xxxxxxxxx

Address : xxxxxxxxx

Email : xxxxxxxxx

Login to see details

Tender Details

Description

1.0 GENERAL INFORMATION

Title: Centralized Institutional Review Board (CIRB) for Minimal Risk Registry Linkage StudiesContracting Office Address:Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Bethesda, MD 20892, USA.

Description:The National Cancer Institute (NCI), Division of Cancer Control and Population Sciences (DCCPS) is seeking to contract with a commercial Institutional Review Board (IRB) to serve as a Central IRB (CIRB) for the intake, processing and review of multi-state/site minimal risk registry linkage studies. The CIRB is intended to streamline the IRB application and review process, thereby saving time and resources associated with multiple local IRB approval processes and is a component of the Virtual Pooled Registry Cancer Linkage System (VPR-CLS) workflow. The requesting investigator must provide evidence of Institutional IRB review and approval (or exemption) to initiate the VPR-CLS linkage request process. Aside from VPR-CLS multi-site studies, the CIRB is also intended to review studies funded by and conducted by National Cancer Institute (NCI) staff within the Division of Cancer Control and Population Studies (DCCPS) or other NCI divisions with a related need for a CIRB review for those studies meeting the definition of minimal-risk and eligible for expedited review.

National Cancer Institute (NCI) Division of Cancer Control and Population Sciences (DCCPS), Surveillance Research Program (SRP), plans to procure on a sole source basis the services of a commercial IRB to serve as the Centralized IRB.This acquisition will be processed in accordance with FAR Part 12 commercial services using FAR Part 13.5 Simplified procedures for Certain Commercial Products and Commercial Services. The North American Industry Classification System code is 541990 - All Other Professional, Scientific, and Technical Services This is not a s...
Active Contract Opportunity Notice ID 75N91024Q00068 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NIH NCI
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Mar 22, 2024 11:00 pm EDT
Original Response Date: Apr 08, 2024 03:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Apr 23, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: R408 - SUPPORT- PROFESSIONAL: PROGRAM MANAGEMENT/SUPPORT
NAICS Code: 541990 - All Other Professional, Scientific, and Technical Services

Place of Performance: USA

Documents

 Tender Notice